*Department of Pharmacy, University Hospital Gran Canaria Doctor Negrín, Las Palmas

†Department of Pharmacy, Catalan Institute of Oncology, L’Hospitalet de Llobregat, Barcelona

‡Department of Pharmacy, University Hospital Virgen Macarena, Seville

§University of Granada

∥Andalusian School of Public Health/Escuela Andaluza de Salud Pública (EASP), Granada

¶CIBER of Epidemiology and Public Health (CIBERESP), Spain

#Instituto de Investigación Biosanitaria ibs

**Department of Oncology, University Hospital Virgen de las Nieves, Granada, Spain

The authors declare no conflicts of interest.

Correspondence: Cristina Fernández-López, PhD, Department of Pharmacy, Catalan Institute of Oncology, Gran Via de l’Hospitalet 199-203, L’Hospitalet de Llobregat 08908. E-mail: [email protected].

Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.amjclinicaloncology.com.